Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 3Unknown 2Completed 2Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 3Sarcoma 2Head & Neck 1CNS 1

Conditions

Sarcoma 2Liposarcoma 2Liposarcoma, Myxoid 1Lipoma 1

Interventions

Doxorubicin 25Radiotherapy 16apatinib 15Cyclophosphamide 15Ifosfamide 13anlotinib 12camrelizumab 10Temozolomide 9Imatinib Mesylate 9Vincristine 8Surgical Procedures, Operative 7Neoadjuvant Therapy 7Methotrexate 7Drug Therapy 7Dactinomycin 5Blood Specimen Collection 5fludarabine phosphate 4Paclitaxel 4Immune Checkpoint Inhibitors 4Etoposide 4Docetaxel 4Carboplatin 4toripalimab 3pembrolizumab 3Trabectedin 3Topotecan 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Nivolumab 3Melphalan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × ribociclib × Sarcoma × Clear all
NCT03096912 2017-10-25

A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Assaf-Harofeh Medical Center

Phase 2 Unknown
30 enrolled
Sarcoma

Lipoma, Liposarcoma, Sarcoma, Liposarcoma, Myxoid

NCT02571829 2016-11-23

A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma

Hadassah Medical Organization

Phase 2 Unknown
30 enrolled
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡